Definitely think that there is a strong role for large academic centers for particular types of cancer and leukemia. All our diseases that we are learning more and more about and using that knowledge to advance our therapeutic interventions. And so both from a knowledge base of making sure that we have all the information from a cytogenetic and genetic standpoint in terms of risk stratifying a patient's particular type of disease, it's also important too because these are the centers that are doing the research. And so I'm a big advocate for patients that are interested in tumor banking, donating some of the excess bone marrow or biopsy tissue for research purposes. Typically this is in a de-identified sort of manner, but that's really what fuels our ability to advance the current state of knowledge and develop the next set of tools.
